StockpollyBeta
Get App
Popularity #3,074
XGN · NASDAQ · Medical - Diagnostics & Research

Exagen (XGN)

Develops AVISE tests for diagnosis and monitoring of autoimmune disease.

$8.74
After hours−0.02 (−0.23%)
At close$8.76(+1.62%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue131414151314151717171720
Cost of revenue666665677778
Gross profit8899789101091012
131312121212121313141414
Research & development111112112221
111211101010111211121213
Selling & marketing100000000000
General & administrative11010101010000000
Operating income−5−5−3−3−5−3−3−3−3−5−3−2
0000000−2−40−1−1
Interest income000000000010
Interest expense111111111111
Other non-operating income000000013−2−10
Income before tax−5−6−3−3−5−4−4−4−7−5−4−3
Income tax expense000000000000
Net income from continuing operations−5−6−3−3−5−4−4−4−7−5−4−3
Net income−5−6−3−3−5−4−4−4−7−5−4−3
EPS, basic−$0.31−$0.31−$0.19−$0.16−$0.28−$0.20−$0.20−$0.21−$0.31−$0.21−$0.17−$0.13
EPS, diluted−$0.31−$0.31−$0.19−$0.16−$0.28−$0.20−$0.20−$0.21−$0.31−$0.21−$0.17−$0.13
Weighted average shares, basic181818181818192123222424
Weighted average shares, diluted181818181818192123222424
EBITDA−4−4−2−2−4−3−3−3−5−3−2−1
Depreciation & amortization110000000111
EBIT−5−5−3−2−4−3−3−3−6−3−3−2